TEI Biosciences Inc. Company Profile

14:10 EST 21st November 2014 | BioPortfolio

A Boston-based, privately-held, leading biomedical company, TEI Biosciences Inc. has applied its expertise in regenerative medicine to develop and commercialize novel biologic products for a broad spectrum of soft tissue repair, regeneration, and reinforcement applications -- from plastic and reconstructive surgery to dura, tendon, and hernia repair, and wound management.

News Articles [652 Associated News Articles listed on BioPortfolio]

Marck Biosciences Ltd - Company Capsule

Recently added to the BioPortfolio report store, Marck Biosciences Ltd - Company Capsule is a new report from ICD Research published on 2011-11-16. This 8-page report is available from $75. ICD Res...

Powertech to Distribute Pressure BioSciences' Lab Tools in China

Powertech Technology, a distributor of laboratory tools based in Xiamen, signed a three-year agreement to distribute Pressure BioSciences' products in China. Pressure BioSciences makes constant and al...

BRIEF-Cardio3 Biosciences says in JV with HK's Medisun International

* Cardio3 Biosciences teams up with Medisun International to create Cardio3 Biosciences Asia Holdings Ltd, a joint venture aimed at conducting pivotal clinical programs in Greater China

Regado Biosciences permanently halts REGULATE-PCI trial

US-based cardiovascular specialist Regado Biosciences Regado Biosciences has announced the permanent termination of enrollment in its REGULATE-PCI Phase III trial for its lead program, Revolixys Kit.

Neurocrine Biosciences, Inc. To Present At The Biotechnology Conference

SAN DIEGO, Nov. 3, 2014 /PRNewswire/ --Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presentin...

Daiichi Sankyo pays $410m for Ambit Biosciences

Daiichi Sankyo has bought San Diego-based Ambit Biosciences in a deal aimed at shoring up the Japanese company’s cancer research. Daiichi says in a statement that it will acquire all of the outstand...

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

Daiichi Sankyo and Ambit Biosciences have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences. Under the terms o...

Regado Biosciences, Inc. - Product Pipeline Review - 2014

Regado Biosciences, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Regado Biosciences, Inc. - Product Pipeline Review - 2014’, provides an overview of the Regado Bioscie...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Companies [299 Associated Companies listed on BioPortfolio]

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Valent BioSciences Corporation

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

BD Biosciences Bioimaging

BD Biosciences Bioimaging gives "sight" to computers, by creating software that captures images from digital cameras and extracts information from those images. We integrate our software into high-per...

More Information about "TEI Biosciences Inc." on BioPortfolio

We have published hundreds of TEI Biosciences Inc. news stories on BioPortfolio along with dozens of TEI Biosciences Inc. Clinical Trials and PubMed Articles about TEI Biosciences Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of TEI Biosciences Inc. Companies in our database. You can also find out about relevant TEI Biosciences Inc. Drugs and Medications on this site too.

Search BioPortfolio:

Relevant Topic

Latest News Clinical Trials Research Drugs Reports Corporate
Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Dictionary). It is an active area of medical research, because of the d...


Corporate Database Quicklinks

Searches Linking to this Company Record